DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» NeuVax
NeuVax
Patient Resource Free
The HER2 Peptide Nelipepimut-S (E75) Vaccine (Neuvax™) in Breast Cancer Patients at Risk for Recurrence: Correlation of Immunologic Data with Clinical Response
Exploring Essential Issues for Improving Therapeutic Cancer Vaccine Trial Design
Breast Cancer Vaccines: New Insights
2018 Medicines in Development for Cancer
Results of a Randomized Phase Iib Trial of Nelipepimut-S + Trastuzumab Vs Trastuzumab to Prevent Recurrences in High-Risk HER2 Low-Expressing Breast Cancer Patients
Clinical Trials: Biologics
A Therapeutic Her2/Neu Vaccine Targeting Dendritic Cells Preferentially Inhibits the Growth of Low Her2/Neu–Expressing Tumor I
Biotechnology Presented by America’S Biopharmaceutical Research Companies
Oncology Dose-Finding Workshop Part 3 Transcript: Session I, Immuno-Oncology (IO) Overview – Scope of the Problem
With Emphasis on HER2-Positive Breast Cancer
Small-Cap Research
[email protected]
Confidential
Understanding Cancer Immunotherapy
Small-Cap Research
[email protected]
For Recurrence Breast Cancer
Clinical Activity of a Htert (Vx-001) Cancer Vaccine As Post
Top View